| 05/05/2026 6:45 AM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 5:44 PM | Eliem Therapeutics (1768446) Subject RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by | Form SCHEDULE 13D/A | |
| 04/29/2026 5:46 PM | Eliem Therapeutics (1768446) Issuer Kolchinsky Peter (1384859) Reporting RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting RA Capital Nexus Fund II, L.P. (1825376) Reporting RA Capital Nexus Fund III, L.P. (1883840) Reporting RA Capital Nexus Fund, L.P. (1780117) Reporting Shah Rajeev M. (1619841) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/28/2026 7:30 AM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/24/2026 3:13 PM | Eliem Therapeutics (1768446) Filer | Form DEF 14A | |
| 04/24/2026 3:15 PM | Eliem Therapeutics (1768446) Filer | Form DEFA14A | |
| 04/24/2026 3:17 PM | Eliem Therapeutics (1768446) Filer | Form ARS | |
| 04/10/2026 3:05 PM | Eliem Therapeutics (1768446) Filer | Form PRE 14A | |
| 04/03/2026 3:05 PM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/05/2026 6:20 AM | Eliem Therapeutics (1768446) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/05/2026 6:30 AM | Eliem Therapeutics (1768446) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for ELYM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/05/2026 6:10 AM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/08/2026 3:05 PM | ALTSCHULLER Susan (1817988) Reporting Eliem Therapeutics (1768446) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 3:05 PM | Eliem Therapeutics (1768446) Issuer Wilson Perrin Megan (2074091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 3:05 PM | Brennan Aoife (1714563) Reporting Eliem Therapeutics (1768446) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 6:07 AM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/07/2026 3:55 PM | Eliem Therapeutics (1768446) Issuer Kolchinsky Peter (1384859) Reporting RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting RA Capital Nexus Fund II, L.P. (1825376) Reporting RA Capital Nexus Fund III, L.P. (1883840) Reporting RA Capital Nexus Fund, L.P. (1780117) Reporting Shah Rajeev M. (1619841) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/31/2025 3:12 PM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/15/2025 6:55 PM | Eliem Therapeutics (1768446) Issuer Kolchinsky Peter (1384859) Reporting RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting RA Capital Nexus Fund II, L.P. (1825376) Reporting RA Capital Nexus Fund III, L.P. (1883840) Reporting RA Capital Nexus Fund, L.P. (1780117) Reporting Shah Rajeev M. (1619841) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 6:56 PM | Eliem Therapeutics (1768446) Subject RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by | Form SCHEDULE 13D/A | |
| 12/11/2025 7:16 AM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/06/2025 6:21 AM | Eliem Therapeutics (1768446) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/06/2025 6:15 AM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 6:11 AM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/16/2025 4:48 PM | AI ETI LLC (1871741) Filed by Eliem Therapeutics (1768446) Subject | Form SCHEDULE 13D/A | |
| 10/07/2025 3:51 PM | AI ETI LLC (1871741) Filed by Eliem Therapeutics (1768446) Subject | Form SCHEDULE 13D/A | |
| 10/01/2025 4:52 PM | ALTSCHULLER Susan (1817988) Reporting Eliem Therapeutics (1768446) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/01/2025 4:49 PM | ALTSCHULLER Susan (1817988) Reporting Eliem Therapeutics (1768446) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 10/01/2025 4:23 PM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/29/2025 6:48 AM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/18/2025 8:26 AM | Eliem Therapeutics (1768446) Subject Pontifax Management 4 G.P. (2015) Filed by | Form SCHEDULE 13G | |
| 08/12/2025 6:10 AM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/12/2025 6:15 AM | Eliem Therapeutics (1768446) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/01/2025 3:32 PM | Eliem Therapeutics (1768446) Issuer Thomas Stephen Basil (2027962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2025 3:15 PM | Eliem Therapeutics (1768446) Issuer Wilson Perrin Megan (2074091) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 06/20/2025 3:15 PM | Eliem Therapeutics (1768446) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 06/20/2025 3:20 PM | Eliem Therapeutics (1768446) Issuer Pimblett Emily (1969365) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/20/2025 3:20 PM | Eliem Therapeutics (1768446) Issuer Driscoll Cindy (1741269) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 6:08 AM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/05/2025 3:21 PM | Eliem Therapeutics (1768446) Issuer Kolchinsky Peter (1384859) Reporting RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting RA Capital Nexus Fund II, L.P. (1825376) Reporting RA Capital Nexus Fund III, L.P. (1883840) Reporting RA Capital Nexus Fund, L.P. (1780117) Reporting Shah Rajeev M. (1619841) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/23/2025 3:32 PM | Eliem Therapeutics (1768446) Filer | Form DEFA14A | |
|
| 05/14/2025 6:05 AM | Eliem Therapeutics (1768446) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/14/2025 6:10 AM | Eliem Therapeutics (1768446) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |